Randomised, double-blind and placebo-controlled study of the effect of a synbiotic dairy product on orocecal transit time in healthy adult women;Estudio aleatorizado, doble-ciego y controlado por placebo del efecto de un simbiótico sobre el tránsito intestinal en mujeres adultas sanas

Nutricion Hospitalaria

Volumn 27, Issue 4, 2012, Pages 1314-1319

  Malpeli, A ^a   Gonzalez S ^b   Vicentin, D ^c   Apas A ^b   Gonzalez H F ^a  

^a Hospital de Niños de La Plata MS CICPBA   (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^c SanCor CUL   (Argentina)

Author keywords

Functional constipation; Intestinal transit time; Synbiotic; Women

Indexed keywords

BIFIDOBACTERIUM; LACTOBACILLUS CASEI;

COLORING AGENT; SYNBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; BIFIDOBACTERIUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAIRY PRODUCT; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE; LACTOBACILLUS; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIFIDOBACTERIUM; COLORING AGENTS; CROSS-OVER STUDIES; DAIRY PRODUCTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINES; LACTOBACILLUS; MIDDLE AGED; PROSPECTIVE STUDIES; SYNBIOTICS; YOGURT; YOUNG ADULT;

EID: 84864303138     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.4.5770     Document Type: Article

References (31)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroen-terology 2006; 130: 1480-1491.
2. Lembo A, Camillieri M. Chronic constipation. N Engl J Med 2003; 349: 1360-1368.
3. Ashraf W, Park F, Lof J, Quigley EM. An examination of the reliability of reported stool frequency in the diagnosis of idio-pathic constipation. Am J Gastroenterol 1996; 91: 26-32.
4. Locke GR, Pemberton JH, Phillips SF. American Gastroen-terological Association Medical Position Statement: guidelines on constipation. Gastroenterology 2000; 119: 1761-1776.
5. Amenta M, Cascio MT, Di Fiore D, VI Diet and C constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11+ FOS Acti-light). Acta Biomed 2006; 77: 157-162.
6. Meance S, Cayuela CH, Turchet P, Raimondi A, Lucas C, Antoine JM. A fermented milk with a bifidobacterium probiotic strain DN-173 010 shortened oro-cecal gut transit time in elderly. Microb Ecol Health Dis 2001; 13: 217-222.
7. Meance S, Cayuela CH, Raimondi A, Turchet P, Lucas C, Antoine JM. Recent advances in the use of functional foods: Effects of the commercial fermented milk with bifidobacterium animalis strain DN-173010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis 2003; 15: 15-22.
8. Marteau P, Cuillerier S, Meance S, Gerhardt MF, Myara A, Bouviers M et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16: 587-593.
9. Koebnick C, Wagner I, Leitzmann B, Stern U, Zunft HJF. Pro-biotics beverage containing Lactobacilus Casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003; 17 (11): 655-659.
10. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439-442.
11. Fuller R. History and development of probiotics. In: Fuller R, editor. Probiotics, the scientific basis. London: Chapman & Hall; 1992, pp. 1-8.
12. Cummings DH, MacFarlane GT, Englyst HN. Prebiotic digestion an fermentation. Am J Clin Nutr 2001; 75 (Suppl.): 415S-420S.
13. Schrezenmeir J, De Vrese M. Probiotics, prebiotics and synbi-otics. Approaching a definition. Am J Clin Nutr 2001; 73 (Suppl.): 361S-364S.
14. Heller KJ. Probiotic bacteria in fermented foods. Product characteristics and starter organism. Am J Clin Nutr 2001; 73 (Suppl.): 374S-379S.
15. Marteau P, Boutron-Ruault MC. Nutritional advantages of pro-biotics and prebiotics. Br J Nutr 2002; 87(SUPPL. 2): S153-S157.
16. Marteau PR, De Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal disease with the use of probiotics. Am J Clin Nutr 2001; 73 (Suppl.): 430S-436S.
17. http://www.romecriteria.org/pdfs/AdultFunctGIQ.
18. Briet F, Pochart P, Marteau P, Fluorie B, Arrigoni E, Rambaud JC. Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? Gut 1997; 41: 632-635.
19. Mc Clure RJ, Newell SJ. Randomised controlled trial of trophic feeding and gut motility. Arch Dis Child Fetal Neonatal Ed 1999; 80: 54-55.
20. Matsumoto M, Tadenuma T, Nakamura K, Kume H, Imai T, Kihara R, Watanabe M, Benno Y. Effect of bifidobacterium lactis LKM 512 yogurt on fecalmicroflora in middle to old aged persons. Microb Ecol Health Dis 2000; 12: 77-80.
21. Matsumoto M, Ohishi H, Benno Y. Impact of LKM 512 yoghurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol 2001; 31: 181-186.
22. Gaon D, Doweck Y, Zavaglia A, Holgado A, Oliver G. Lactose digestion by milk fermented with human strains of lactobacillus acidophilus and lactobacilus casei Medicina (Buenos Aires) 1995; 55: 237-242.
23. Chmielewska A, Szajewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. WJG 2010; 16 (1): 69-75.
24. De Paula JA, Carmuega E, Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation. Acta Gastroenterol Latinoam 2008; 38: 16-25.
25. Dughera L, Elia Ch, Navino M, Cisarò F and the ARMONIA Study Group. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed 2007; 78 (2): 111-116.
26. Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D; Symbiotic Study Group. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multi-center study. Minerva Gastroenterol Dietol 2006; 52: 349-358.
27. Shioya M, Nakaoka K, Igarashi R, Iizuka N, Abe T, Benno Y. Effect of fermented milk containing Bifidobacterium lactis FK 120 on the fecal flora and fecal properties in healthy female volunteers. J Nutr Food 2000; 3 (1): 7-18.
28. Shioya M, Nakaoka K, Iizuka N, Benno Y. Effect of fermented milk containing Bifidobacterium lactis FK 120 on the fecal flora, with special reference to Bifidobacterium species, and the fecal properties in healthy volunteers. J Nutr Food 2000; 3 (1): 19-32.
29. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-1189.
30. De Giorgio R, Barbara G, Stanghellini V, Cremon C, Salvioli B, De Ponti F, Corinaldesi R. Diagnosis and therapy of irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20 (SUPPL. 2): 10-22.
31. O'Mahoney L, Mc Carthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacteruim in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gas-troenterology 2005; 128 (3): 541-551.